HPV and Pap Test Results: Next Steps after an Abnormal Cervical Cancer Screening Test - NCI
Atypical squamous cells
Follow-up testing after colposcopy: five-year risk of CIN 2+ after a colposcopic diagnosis of CIN 1 or less. - Abstract - Europe PMC
Performance of p16INK4a-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results - Gynecologic Oncology
Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management. - Abstract - Europe PMC
Cervical intraepithelial neoplasia - Wikipedia
Colposcopy and treatment of cervical intraepithelial neoplasia: a beginners' manual
Guidelines for Cervical Cancer Screening and Prevention
Session 3 OBGYN: L4 Pap Test and Cervical CA Flashcards | Quizlet
Cervical intraepithelial neoplasia: Management - UpToDate
Cervical intraepithelial neoplasia: Management - UpToDate
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. - Abstract - Europe PMC
Challenges of false positive and negative results in cervical cancer screening | medRxiv
Accuracy of screening tests for CIN 2+ compared with pathology. | Download Table
HPV-positive women with normal cytology remain at increased risk of CIN3 after a negative repeat HPV test | British Journal of Cancer
Cervical intraepithelial neoplasia: Management - UpToDate
HPV Testing
Cervical intraepithelial neoplasia: Management - UpToDate
Accuracy of screening tests for CIN 2+ compared with pathology. | Download Table
Cervical intraepithelial neoplasia: Management - UpToDate
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Colposcopy and treatment of cervical intraepithelial neoplasia: a beginners' manual
Medicina | Free Full-Text | Key Molecular Events in Cervical Cancer Development | HTML
Cervical Neoplasia and Carcinoma - Obstetrics and Gynecology 7 Ed.
Cervical Screening and HPV Testing
Outcome of expectant management of cervical intraepithelial neoplasia grade 2 in women followed for 12 months - ScienceDirect
Test of Cure after treatment for HSIL (CIN2/3) | Cancer Council
